NFKB1 and ovarian carcinoma: It is reported that NF-κB can also influence the expression of BCL-2 proteins and that constitutive NF-κB activation has been observed in many cancers resistant to antitumor agents (including SK-OV-3 ovarian cancer cells) [10, 11].